WO/2005/049829 is referenced by 4 patents.

The invention relates to a set of isolated marker genes comprising at least one gene identified as having differential expression as between patients who are responders and non responders to an erbB receptor tyrosine kinase inhibitor; said gene set comprising one or more genes selected from at least the group consisting of the (51) genes listed herein including gene-specific oligonucleotides derived from said genes; and uses of sauch sets in diagnostic applications.

Title
Process
Application Number
PCT/GB2004/002316
Publication Number
2005/049829
Application Date
June 1, 2004
Publication Date
June 2, 2005
Inventor
Fukuoka Masahiro
Sone Saburo
Nakamura Yusuke
Tsuruo Takashi
Agent
MASCHIO Antonio
Assignee
Fukuoka Masahiro
Sone Saburo
Nakamura Yusuke
Tsuruo Takashi
The University Of Tokyo
Astrazeneca
IPC
C07K 14/47
View Original Source